Skip to search formSkip to main contentSkip to account menu

binifibrate

Known as: 3-pyridine carboxylic acid 2-(2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy)-1,3-propanediyl ester 
A fibrate derivative with antilipidemic activity. Binifibrate consists of two nicotinic radicals and one clofibiric radical esterified by a glycerol… 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

AntopalBiniwas

Broader (2)

Hypolipidemic AgentsNicotinic Acids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
[Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
A multicentric, double-blind and randomized clinical study was conducted on a total of 54 patients with hyperlipidemias type IIa… 
1990
1990
Changes in blood viscosity and erythrocyte deformability in patients with dyslipidemia treated with binifibrate
1983
1983
Microhaemorheological properties of binifibrate. Part I: Experimental studies.
The microhaemorheological properties of 3-pyridine carboxylic acid 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]-1,3-propanediyl… 
1983
1983
Microhaemorheological properties of binifibrate. Part II: Preliminary open studies in patients with peripheral arteriopathies.
3-Pyridinecarboxylic acid 2-[2-(4-chlorophenoxy)-2-methyl-1-oxo-propoxy]-1,3-propanediyl ester (binifibrate, Biniwas) an anti…